Petersen Ronald C, O'Brien John
Mayo Clinic College of Medicine, Department of Neurology, Rochester, MN 55905, USA.
J Geriatr Psychiatry Neurol. 2006 Sep;19(3):147-54. doi: 10.1177/0891988706291085.
Mild cognitive impairment is a topic of great activity from both clinical and research perspectives. It represents a transitional state between the cognitive changes of aging and the earliest clinical manifestations of dementia. We present a case for its inclusion in the Diagnostic and Statistical Manual of Mental Disorders (5th ed; DSM-V) based on clinical, outcome, epidemiological, neuroimaging, and pathophysiological data. The strongest case for inclusion can be made for the amnestic subtype, which is likely a clinical precursor of Alzheimer's disease. Arguments are presented as to why mild cognitive impairment can be considered as an entity distinct from normal aging and from clinically probable Alzheimer's disease and why it deserves consideration as a separate construct. In many respects, mild cognitive impairment fulfills criteria for inclusion more adequately than many other conditions currently codified in DSM-IV. Future research directions to help clarify some of the remaining uncertainties are proposed.
从临床和研究角度来看,轻度认知障碍都是一个热门话题。它代表了衰老导致的认知变化与痴呆最早临床表现之间的过渡状态。我们基于临床、转归、流行病学、神经影像学和病理生理学数据,提出将其纳入《精神疾病诊断与统计手册》(第5版;DSM-V)的理由。将遗忘型亚型纳入的理由最为充分,它可能是阿尔茨海默病的临床前驱症状。文中阐述了为何轻度认知障碍可被视为有别于正常衰老和临床可能的阿尔茨海默病的一种实体,以及为何它值得作为一个单独的概念来考虑。在许多方面,轻度认知障碍比目前编入DSM-IV的许多其他病症更充分地满足纳入标准。文中还提出了未来的研究方向,以帮助澄清一些尚存的不确定性。